Clinical Trials Directory

Trials / Completed

CompletedNCT00885456

Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT

Effectiveness of a Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke: A Multi-site RCT

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
187 (actual)
Sponsor
Marilyn MacKay-Lyons · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

The objective of the Program of Rehabilitative Exercise and Education to avert Vascular Events after Non-disabling stroke and Transient ischemic attack (PREVENT) Trial is to determine whether the timely delivery of secondary stroke prevention strategies will reduce modifiable vascular risk factors in two groups of people who have survived NDS or TIA. One group will receive a comprehensive education and exercise program (PREVENT); the other group will receive usual care (USUAL CARE). We will measure modifiable vascular risk factors in both groups. We will also compare the effects of PREVENT vs USUAL CARE on exercise capacity, walking endurance, and daily physical activity. In addition, we will compare thinking ability, depression, achievement of personal goals for healthy behavior, and health-related goal attainment and health-related quality of life. Finally, we will compare outcomes in urban and rural settings as well as costs of the PREVENT program and USUAL CARE in order to assess sustainability of the PREVENT program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPREVENT program12-week program of aerobic/strengthening exercises and education designed to induce physiological and behavioral changes deemed necessary to reduce vascular risk
BEHAVIORALUsual CareThree or more out-patient visits to the neurovascular clinic for assessment, counseling and referral to appropriate health care professionals.

Timeline

Start date
2011-10-30
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2009-04-22
Last updated
2018-03-23

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT00885456. Inclusion in this directory is not an endorsement.